Lilly Forteo Risk Management Program Limits Launch To 8,000 Doctors
Executive Summary
Lilly's launch of Forteo will be focused on 8,000 physicians identified by the company as specializing in severe osteoporosis
You may also be interested in...
Liraglutide Cancer Signal Puts Agency In Uncharted Review Territory
Approving Novo Nordisk's Victoza (liraglutide) for type 2 diabetes would require FDA to surmount a substantial hurdle in the thyroid cancer signal seen with the GLP-1 analog
Liraglutide Cancer Signal Puts Agency In Uncharted Review Territory
Approving Novo Nordisk's Victoza (liraglutide) for type 2 diabetes would require FDA to surmount a substantial hurdle in the thyroid cancer signal seen with the GLP-1 analog
Lilly Strattera Medicaid Reimbursement In 42 States; Launch Beats Lexapro
Lilly's Strattera has gained Medicaid reimbursement in 42 states in the three months since the launch of the attention deficit disorder drug, Investor Relations Manager Craig Hartman told investors April 22